We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FORA
4076
DELISTED
Forian
FORA
$12K ﹤0.01%
3,260
-977
-23% -$3.4K
GRSD
4077
Grandstand Limited Ordinary Shares
GRSD
$80.4M
$12K ﹤0.01%
1,203
+373
+45% +$3.58K
GGLL icon
4078
Direxion Daily GOOGL Bull 2X ETF
GGLL
$954M
$12K ﹤0.01%
+541
New +$10.9K
GNK icon
4079
Genco Shipping & Trading
GNK
$1.15B
$12K ﹤0.01%
787
+669
+567% +$11.5K
B
4080
Barrick Mining
B
$68.5B
$12K ﹤0.01%
632
-20,404
-97% -$367K
GSUS icon
4081
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.32B
$12K ﹤0.01%
211
-2,204
-91% -$120K
HEWJ icon
4082
iShares Currency Hedged MSCI Japan ETF
HEWJ
$766M
$12K ﹤0.01%
411
+20
+5% +$556
HLIO icon
4083
Helios Technologies
HLIO
$2.69B
$12K ﹤0.01%
180
-255
-59% -$16.6K
HYFM icon
4084
Hydrofarm Holdings
HYFM
$7M
$12K ﹤0.01%
655
-789
-55% -$14K
HYMC icon
4085
Hycroft Mining Holding Corp
HYMC
$2.52B
$12K ﹤0.01%
2,735
+724
+36% +$3.53K
ICCC icon
4086
ImmuCell
ICCC
$90.9M
$12K ﹤0.01%
2,335
+1,059
+83% +$6.88K
IMMX icon
4087
Immix Biopharma
IMMX
$781M
$12K ﹤0.01%
6,375
+4,019
+171% +$8.88K
INSE icon
4088
Inspired Entertainment
INSE
$164M
$12K ﹤0.01%
905
-1,102
-55% -$15.9K
ITOS
4089
DELISTED
iTeos Therapeutics
ITOS
$12K ﹤0.01%
898
+513
+133% +$9.19K
KINS icon
4090
Kingstone Companies
KINS
$285M
$12K ﹤0.01%
8,667
+5,744
+197% +$8.44K
LAB icon
4091
Standard BioTools
LAB
$280M
$12K ﹤0.01%
6,234
-17,289
-73% -$34.2K
LAND
4092
Gladstone Land Corp
LAND
$358M
$12K ﹤0.01%
719
+357
+99% +$6.45K
LFMD icon
4093
LifeMD
LFMD
$166M
$12K ﹤0.01%
6,918
+5,733
+484% +$10.1K
LUNG icon
4094
Pulmonx
LUNG
$104M
$12K ﹤0.01%
1,067
-19,140
-95% -$189K
MAX icon
4095
MediaAlpha
MAX
$807M
$12K ﹤0.01%
790
-6,432
-89% -$87K
MBI icon
4096
MBIA
MBI
$264M
$12K ﹤0.01%
1,321
-1,639
-55% -$19.6K
MBRX icon
4097
Moleculin Biotech
MBRX
$4.35M
$12K ﹤0.01%
33
+19
+136% +$8.32K
MCHX icon
4098
Marchex
MCHX
$82M
$12K ﹤0.01%
6,776
-12,763
-65% -$24.6K
MITQ icon
4099
Moving iMage Technologies
MITQ
$5.47M
$12K ﹤0.01%
12,027
+6,446
+115% +$7.45K
MNTS icon
4100
Momentus
MNTS
$91.2M
$12K ﹤0.01%
2
+1
+100% +$10.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.